facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2017
vol. 104
 
Share:
Share:
abstract:
Review paper

Drug hypersensitivity reactions and allergy in patients with mastocytosis

Justyna H. Czarny
,
Magdalena Lange
,
Marek B. Niedoszytko
,
Barbara Kwiecińska
,
Aleksandra Górska
,
Hanna Ługowska-Umer
,
Monika Sikorska
,
Roman Nowicki

Przegl Dermatol 2017, 104, 22–30
Online publish date: 2017/03/03
View full text Get citation
 
PlumX metrics:
Mastocytosis is a rare myeloproliferative disease caused by excessive proliferation and accumulation of mast cells in the skin and internal organs. The most common variant of mastocytosis in children is cutaneous mastocytosis. Systemic mastocytosis dominates in adults. Both CM and SM patients suffer from mast cell mediator-related symptoms such as itching, flushing, hypotension, abdominal pain, diarrhea, headache and anaphylaxis. The prevalence of anaphylaxis in patients with mastocytosis has been estimated to be about 50% in adults and about 9% in children. Anaphylaxis may be caused by many triggers including hymenoptera sting, drugs, physical factors, exercise, infections, alcohol, some food types and allergens. Drugs which may provoke anaphylaxis include nonsteroidal anti-inflammatory drugs, antibiotics, opioids, contrast media and muscle relaxants. Appropriate preparation of a patient for medical procedures and long-term prophylaxis allow one to reduce the risk of anaphylaxis in patients with mastocytosis.
keywords:

drugs, prophylaxis, mastocytosis, anaphylaxis



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.